ENYO Pharma conducts Phase I clinical trial of EYP001 to treat hepatitis infection

French biopharmaceutical company ENYO Pharma is conducting its Phase I single and multiple ascending dose trial of EYP001 to treat Chronic Hepatitis B (CHB) Virus infection.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news